Fuente: FierceBiotech With sales of Immunocore’s melanoma medicine steadily ticking up, an expanded label likely down the line and a longtime colleague no longer at her side, CEO Bahija Jallal, Ph.D., is mixing caution with ambition as she adjusts to working without a longtime colleague at her side.